OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth -6.2% ·
share flow +4.4% ·
net new positions -6.7%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 51.82K | $1.76M | n/a | n/a |
| Q2 2026 | 99 | +2 | 36.95M | $1.52B | +8 | −6 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | n/a |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | n/a | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | n/a |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | n/a | −1 |
| Q2 2024 | 13 | n/a | 3.69M | $99.83M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.83M | n/a | $230.31M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 5.64M | n/a | $165.71M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.09M | -3.4% | $61.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.42M | +1.9% | $41.80M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (passive) | 1.20M | +2.6% | $35.16M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 898.22K | +265.0% | $26.41M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 804.16K | +61.9% | $23.64M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 8 | Point72 Asset Management ✦ | 332.80K | New | $9.78M | 0.0% | New | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 305.54K | +7.0% | $8.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 288.96K | +29.5% | $8.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 217.89K | n/a | $6.41M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Arrowstreet Capital ✦ | 144.42K | +13.5% | $4.25M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 90.43K | +404.2% | $2.66M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 49.67K | +8.5% | $1.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 25.02K | -46.4% | $735,441 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $9.78M | 0.0% |
Exited
| Millennium Management | $13.68M | was 0.0% |
| Marshall Wace | $4.80M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 5.77M shares, $5.60M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.